These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 31054362)

  • 1. The role of MiRNA in polycystic ovary syndrome (PCOS).
    Chen B; Xu P; Wang J; Zhang C
    Gene; 2019 Jul; 706():91-96. PubMed ID: 31054362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs related to androgen metabolism and polycystic ovary syndrome.
    Sørensen AE; Udesen PB; Wissing ML; Englund ALM; Dalgaard LT
    Chem Biol Interact; 2016 Nov; 259(Pt A):8-16. PubMed ID: 27270454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of microRNAs and genes associated with hyperandrogenism in the follicular fluid of women with polycystic ovary syndrome.
    Xue Y; Lv J; Xu P; Gu L; Cao J; Xu L; Xue K; Li Q
    J Cell Biochem; 2018 May; 119(5):3913-3921. PubMed ID: 29193229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of microRNA in the Pathogenesis of Polycystic Ovary Syndrome.
    Chen Z; Ou H; Wu H; Wu P; Mo Z
    DNA Cell Biol; 2019 Aug; 38(8):754-762. PubMed ID: 31305133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review.
    Nasser JS; Altahoo N; Almosawi S; Alhermi A; Butler AE
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of differentially expressed microRNAs in the ovary of polycystic ovary syndrome with hyperandrogenism and insulin resistance.
    Lin L; Du T; Huang J; Huang LL; Yang DZ
    Chin Med J (Engl); 2015 Jan; 128(2):169-74. PubMed ID: 25591557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of microRNA profile in human cumulus granulosa cells: Identification of microRNAs that regulate Notch signaling and are associated with PCOS.
    Xu B; Zhang YW; Tong XH; Liu YS
    Mol Cell Endocrinol; 2015 Mar; 404():26-36. PubMed ID: 25622783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A review.
    Abdalla M; Deshmukh H; Atkin SL; Sathyapalan T
    Life Sci; 2020 Oct; 259():118174. PubMed ID: 32745529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epigenetics of polycystic ovary syndrome].
    Concha C F; Sir P T; Recabarren SE; Pérez B F
    Rev Med Chil; 2017 Jul; 145(7):907-915. PubMed ID: 29182200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNAs: Emerging Modulators in the Pathophysiology of Polycystic Ovary Syndrome and their Clinical Implications.
    Mazloomi S; Mousavi V; Aghadavod E; Mafi A
    Curr Mol Med; 2024; 24(2):153-166. PubMed ID: 36627779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs Related to Polycystic Ovary Syndrome (PCOS).
    Sørensen AE; Wissing ML; Salö S; Englund AL; Dalgaard LT
    Genes (Basel); 2014 Aug; 5(3):684-708. PubMed ID: 25158044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of miRNA - 320 expression level and its target gene endothelin-1 with the susceptibility and clinical features of polycystic ovary syndrome.
    Rashad NM; Ateya MA; Saraya YS; Elnagar WM; Helal KF; Lashin ME; Abdelrhman AA; Alil AE; Yousef MS
    J Ovarian Res; 2019 May; 12(1):39. PubMed ID: 31064393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA expression in PCOS: unveiling a paradigm shift toward biomarker discovery.
    Rashid G; Khan NA; Elsori D; Youness RA; Hassan H; Siwan D; Seth N; Kamal MA; Rizvi S; Babker AM; Hafez W
    Arch Gynecol Obstet; 2024 May; 309(5):1707-1723. PubMed ID: 38316651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes.
    Sørensen AE; Wissing ML; Englund AL; Dalgaard LT
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1579-89. PubMed ID: 26771704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside-A Systematic Literature Review.
    Vitale SG; Fulghesu AM; Mikuš M; Watrowski R; D'Alterio MN; Lin LT; Shah M; Reyes-Muñoz E; Sathyapalan T; Angioni S
    Biomedicines; 2022 Jul; 10(8):. PubMed ID: 36009364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNAs expression profiling of rat ovaries displaying PCOS with insulin resistance.
    Zhang C; Yu C; Lin Z; Pan H; Li K; Ma H
    Arch Gynecol Obstet; 2020 Nov; 302(5):1205-1213. PubMed ID: 32757043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated miR-142, -33b and -423 in granulosa cells target TGFBR1 and SMAD7: a possible role in polycystic ovary syndrome.
    Li Y; Xiang Y; Song Y; Wan L; Yu G; Tan L
    Mol Hum Reprod; 2019 Oct; 25(10):638-646. PubMed ID: 30865275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Let-7e modulates the proliferation and the autophagy of human granulosa cells by suppressing p21 signaling pathway in polycystic ovary syndrome without hyperandrogenism.
    Li Y; Liu YD; Zhou XY; Zhang J; Wu XM; Yang YZ; Chen YX; Zhang XF; Li X; Ma LZ; Wang Z; Chen SL
    Mol Cell Endocrinol; 2021 Sep; 535():111392. PubMed ID: 34246727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.